Cibc Private Wealth Group, LLC Pacira Bio Sciences, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 83 shares of PCRX stock, worth $1,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83Holding current value
$1,934% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
255Shares Held
50.8MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$122 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$52.8 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$52.2 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$47.8 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.07B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...